Short Interest in NanoVibronix, Inc. (NASDAQ:NAOV) Expands By 23.6%

NanoVibronix, Inc. (NASDAQ:NAOVGet Rating) was the target of a significant growth in short interest in April. As of April 15th, there was short interest totalling 703,600 shares, a growth of 23.6% from the March 31st total of 569,100 shares. Based on an average daily trading volume, of 1,460,000 shares, the days-to-cover ratio is presently 0.5 days.

Hedge funds have recently modified their holdings of the business. Jane Street Group LLC acquired a new stake in shares of NanoVibronix in the 3rd quarter valued at $31,000. Morgan Stanley acquired a new stake in shares of NanoVibronix in the 3rd quarter valued at $40,000. Squarepoint Ops LLC acquired a new stake in shares of NanoVibronix in the 3rd quarter valued at $57,000. Bank of New York Mellon Corp acquired a new stake in shares of NanoVibronix in the 3rd quarter valued at $69,000. Finally, State Street Corp acquired a new stake in shares of NanoVibronix in the 2nd quarter valued at $35,000. 6.80% of the stock is currently owned by hedge funds and other institutional investors.

NASDAQ:NAOV traded down $0.01 during trading hours on Tuesday, reaching $0.68. 107,016 shares of the company were exchanged, compared to its average volume of 351,320. NanoVibronix has a 1-year low of $0.65 and a 1-year high of $4.19. The business has a 50 day moving average of $0.83 and a 200 day moving average of $1.01.

NanoVibronix Company Profile (Get Rating)

NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing.

Recommended Stories

Receive News & Ratings for NanoVibronix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoVibronix and related companies with MarketBeat.com's FREE daily email newsletter.